Data Review on COVID-19 Vaccines for Kids to Get Underway
The United States Food and Drug Administration (FDA) will review 2 months of safety data from clinical trials on the safety and efficacy of COVID-19 vaccines among children ages 5 to 11. This suggests that COVID-19 vaccine manufacturers…